However, G207-NKG2D BiTE virus may complement this treatment strategy, as the sublethal pretreatment of GBM cells with radiation and TMZ may serve to further sensitize them to increased NKG2D BiTE activity. This evidence concerns the gene KLRK1 and glioblastoma.